Our research group is focused on developing targeted therapies for vascular calcification. Cardiovascular disease is the leading cause of death in America and current treatments often result in greater complications. Polymers and nanoparticles offer limitless opportunities to treat vascular calcification in a more effective manner than the traditional approaches. We are currently working to develop three different targeted therapy treatments for vascular calcification.